Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services
Part of paid clinical trials in Lebanon, New Hampshire.
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Study ID
- NCT07195513
- Status
- Recruiting
Conditions
- Advanced Cancer
- Metastatic Cancer (Different Solid Tumour Types)
- Palliative Care Referral
- Palliative Care, Health Services
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ePRO-Directed Referral and Navigation to Palliative/Supportive Care — BEHAVIORALThis intervention combines routine electronic patient-reported outcome (ePRO) symptom monitoring with additional components designed to connect patients more directly to palliative/supportive care. In addition to weekly ePRO symptom surveys, participants complete a monthly palliative care-focused ePRO survey, receive structured palliative care education from a trained study coordinator, and are offered navigation support to facilitate access to palliative/supportive care services. Severe or persistent symptoms or unmet needs reported on ePROs generate an alert to the oncology team along with a recommendation for palliative care referral. This multicomponent approach is intended to address gaps in timely referral and access to palliative/supportive care that are not addressed through symptom monitoring alone.
- ePRO Symptom Monitoring with Usual Palliative Care Referral — OTHERParticipants will be offered weekly electronic patient-reported outcome (ePRO) symptom monitoring surveys and instructions on contacting the oncology team for symptom management. Referral to palliative care occurs according to usual clinical practice. Current standard of care processes for managing symptoms at DCC vary across clinics and may or may not include ePRO monitoring based on the practice of the individual clinician and disease team. Unlike the intervention arm, participants do not receive structured palliative care education, a monthly palliative care-focused ePRO survey, navigation support, or referral alerts generated from persistent or severe symptoms and unmet care needs.
Study Details
This study is testing whether electronic surveys can help patients with advanced cancer report their symptoms and care needs so their doctors can connect them to palliative/supportive care services sooner. The goal is to see if this approach can make it easier for patients to get support for symptoms, quality of life, and other needs during cancer treatment.
Key Dates
- Start date
- Feb 25, 2026
- Status verified
- Mar 2026
- Primary completion
- Apr 30, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: ePRO-Directed Referral InterventionParticipants receive: (1) palliative care education from a trained study coordinator; (2) weekly electronic patient-reported outcome (ePRO) symptom monitoring surveys; (3) monthly ePRO palliative care surveys; and (4) navigation to palliative care services when a referral is placed. Severe or persistent patient-reported symptoms or unmet care needs identified through ePROs will trigger an alert to the oncology team with a recommendation for palliative care referral.
- Other: ePRO Symptom Monitoring with Usual Palliative Care ReferralParticipants will be offered weekly electronic patient-reported outcome (ePRO) symptom monitoring surveys and instructions on contacting the oncology team for symptom management. Referral to palliative care occurs according to usual clinical practice. Current standard of care processes for managing symptoms at DCC vary across clinics and may or may not include ePRO monitoring based on the practice of the individual clinician and disease team.
Primary Outcome Measure
Feasibility of the Intervention & Trial Methods [ Time Frame: 12 and 24 weeks ]
Central Contacts
- Delaney K Reese, MS603-650-3784
- Loretta H Pearson, MPhil, CCRC603-653-3561
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 |
Find similar trials in Lebanon, NH
By research site
Related Studies
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab MonotherapyPHASE1/PHASE2 · Recruiting · 7 Hills Pharma, LLC · Aurora, Colorado
- Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced CancerRecruiting · Alliance Foundation Trials, LLC. · Phoenix, Arizona
- Psychophysical Studies of Cancer Therapy PainRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California